DCGO:NSD-DocGo Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 4.24

Change

-0.08 (-1.85)%

Market Cap

USD 0.41B

Volume

0.32M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-31 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

+0.01 (+0.01%)

USD 8.25B
OPCH Option Care Health Inc

-0.50 (-2.16%)

USD 4.00B
ACHC Acadia Healthcare Company Inc

+1.12 (+2.82%)

USD 3.78B
AMED Amedisys Inc

+0.11 (+0.12%)

USD 2.81B
LFST Lifestance Health Group Inc

+0.18 (+2.44%)

USD 2.74B
SGRY Surgery Partners Inc

+0.12 (+0.57%)

USD 2.59B
ADUS Addus HomeCare Corporation

-1.09 (-0.87%)

USD 2.27B
ASTH Astrana Health Inc

+0.67 (+2.12%)

USD 1.89B
AVAH Aveanna Healthcare Holdings In..

-0.06 (-1.31%)

USD 1.04B
HCSG Healthcare Services Group Inc

-0.16 (-1.33%)

USD 0.84B

ETFs Containing DCGO

DSPC 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -24.15% 54% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -24.15% 54% F 30% F
Trailing 12 Months  
Capital Gain -17.99% 58% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.99% 58% F 33% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -16.68% 33% F 14% F
Dividend Return -16.68% 30% F 14% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.27% 74% C 62% D
Risk Adjusted Return -55.09% 22% F 12% F
Market Capitalization 0.41B 58% F 59% D-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.